STOCK TITAN

Planned sale of 1,678 shares by insider of company (NASDAQ: INSM)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An insider has filed a notice to sell 1,678 common shares of the issuer through Merrill Lynch on or about 01/07/2026 on the NASDAQ. The filing lists an aggregate market value of 293,935 for these planned sales, compared with 213,273,469 shares outstanding for the issuer.

The shares to be sold were acquired on 01/05/2026 as stock plan activity from the issuer. The notice also discloses that Sara Bonstein sold 1,517 common shares on 01/06/2026, generating gross proceeds of 262,941 over the past three months.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many INSM shares are planned to be sold under this Form 144 notice?

The notice covers a planned sale of 1,678 common shares of the issuer’s stock, to be sold through Merrill Lynch on the NASDAQ, with an aggregate market value of 293,935.

When and how were the INSM shares being sold acquired?

The 1,678 common shares are reported as acquired on 01/05/2026 via stock plan activity from the issuer, with the amount of securities acquired matching the planned sale amount.

What is the approximate sale date and trading venue for these INSM shares?

The approximate sale date stated is 01/07/2026, and the securities are expected to be sold on the NASDAQ through Merrill Lynch, 1800 K St NW, Suite 800, Washington, DC 20006.

How many INSM shares are outstanding according to this notice?

The filing states that the number of shares or other units outstanding for the issuer is 213,273,469 common shares at the time referenced.

What INSM stock sales by the same person occurred in the past three months?

The document reports that Sara Bonstein, at an address in Bridgewater, NJ, sold 1,517 common shares on 01/06/2026, with gross proceeds of 262,941 during the past three months.

What representation does the seller make about non-public information on INSM?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Insmed Inc

NASDAQ:INSM

INSM Rankings

INSM Latest News

INSM Latest SEC Filings

INSM Stock Data

33.97B
210.98M
0.65%
101.25%
5%
Biotechnology
Pharmaceutical Preparations
Link
United States
BRIDGEWATER